Ich hab mich mal in Valeant seite ansgeschaut was alles Valeant so an Pharma Unternehmen besitzt...Ich kann nur sagen der Wert vom heute ist geschenkt!.
INVESTOR RELATIONS
Valeant Pharmaceuticals International, Inc., (NYSE: VRX) (TSX: VRX) completed its acquisition of Bausch + Lomb on August 5, 2013. Bausch + Lomb will retain its name and become a division of Valeant. Valeant's existing ophthalmology businesses will be integrated into the Bausch + Lomb division, creating a global eye health platform with estimated pro forma 2013 net revenue of more than $3.5 billion. For Investor Relations information on Valeant, click here. ich würde mal sagen 40$-100$....
|